In the world of peptide research, few synthetic constructs have garnered as much attention as the padre peptide sequence. As a user who frequently interacts with various synthetic compounds for laboratory study, I have found that understanding the structural integrity and the specific biochemical profile of this molecule is essential for anyone looking into immu PADRE peptide AKFVAAWTLKAAA nological research models.
Defining the PADRE Peptide
The PADRE (Pan-DR-binding epitope) is a synthetic, 13-amino acid peptide that has become a staple in modern investigative workflows. Its primary appeal lies in its function as a universal peptidic epitope. U Pan DR binding sequence provides T-cell help for induction of nlike naturally occurring sequences that may show restricted binding, the PADRE peptide was specifically engineered for promiscuous binding to multiple HLA class II DR alleles.
When I look at the technical specifications, the sequence: AKFVAAWTLKAAA is the gold standard for this molecule. This specific arrangement—Ala-Lys-Phe-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-Ala—is often referenced in literature as a vital tool for those studying T-cell help.
Technical Specifications and Synthesis
For those involved in sourcing, it is important to verify the purity and chemical structure of the compound. The H-AKFVAAWTLKAAA-OH configuration is standard, and high-quality preparations typically boast a purity of >95% via HPLC/MS.
Key attributes I look for include:
* Molecular Weight: Approximately 1347.61 g/mol.
* by S Cao·2026—Therefore, attachingPADREto the MITDsequenceoffers a novel strategy to enhance cellular immune responses induced by DNA vaccines targeting pancreatic cancer Read more Formula: C65H102N16O15.
* Structure: It is a linear sequence, though some advanced designs incorporate modifications like D-alanine, L-cyclohexylalanine, and aminohexanoic The PADRE epitope delivers help for fucopentose-specific acid to enhance stability or binding affinity.
Insights into the PADRE Sequence
The PADRE sequence (AKFVAAWTLKAAA) is widely utilized because it provides a consistent pan-DR epitope (PADRE) peptide framework. In my experience reviewing various protocols, the AKFVAAWTLKAA variant is sometimes discussed, but the 13-amino acid version remains the most frequent point of reference.
When researchers discuss pan-DR epitopes (PADRE) peptides, they are often highlighting how these molecules act as a bridge. For instance, I have noted studies where two copies of Aβ1–11 fused with the promiscuous nonself T cell epitope, PADRE were used to explore specific molecular interactions. This illustrates the versatility of the PADRE construct; it is not just a standalone molecule but a modular component that can be fused to other sequences, such as HA epitope 1 - HA epitope 2 - M epitope 9, to create complex, multi-epitope constructs.
Practical Observations
In laboratory settings, the peptide is often handled as a lyophilized powder. Whether you are working with a PADRE peptides mix formulated with IFA or exploring a pan HLA-DR epitope (PADRE) in a custom vaccine design, the stability of the 13 amino acid no Purity. >95% ; Catalog Number. LT8198 ; Molecular Weight. 1347.63 ; Formula. C65H102N16O15 ; Sequence.AKFVAAWTLKAAA, Ala - Lys - Phe - Val - Ala - Ala - Trp - Thr Read more nnatural pan DR epitope (PADRE) is a significant advantage.
The PADRE is a universal synthetic 13 amino acid peptide that continues to be a subject of fascination due to its ability to activate Combined prophylactic and therapeutic immune responses specific cellular responses. If you are examining the padre peptide, ensure that the documentation confirms the sequence: AKFVAAWTLKAAA precisely, as variations in the C-terminus or N-terminus can influence experimental outcomes.
Conclusion
Whether you are a seasoned researcher or just beginning to explore the utility of synthetic epitopes, the PADRE peptide offers a reliable, well-characterized scaffold. By focusing on the AKFVAAWTLKAAA sequence and adhering to rigorous handling standards, one can effectively utilize this epi-based tool to further investigate the complexities of immune recognition and peptide-MHC interactions. Always prioritize sourcing from vendors who provide clear HPLC/MS data to ensure your padre peptide meets the necessary cr Pan-DR binding polypeptides and uses thereof iteria for your specific research goals.